SUMMARY
In 12 spontaneously breathing intubated children (9.3-25 kg) , ventilatory responses to rebreathing and to the inhalation of carbon dioxide (CO 2 ) were investigated during halothane anaesthesia for minor surgical procedures. A 1-piece (Mapleson F system) was used, modified by the insertion of a pneumotachograph and a paediatric airway adaptor of an in-line capnograph in the patient limb. Exhaled gas was collected for determination of expired CO 2 content. Measurements were made when the fresh gas flow (FGF) was at the borderline for rebreathing (FGF r In the present study the ventilatory responses to rebreathing caused by low fresh gas flows and by the addition of CO, to inspired gas were studied during halothane anaesthesia in spontaneously breathing children. Relationships between actual minute ventilation, fresh gas flow and maximal inspired CO, concentrations were determined and the clinical importance of rebreathing evaluated.
PATIENTS AND METHODS
The ventilatory responses to rebreathing at low fresh gas flows (FGF) and to the inhalation of CO, as reflected by minute ventilation (FE), tidal volume (FT), respiratory rate (/) and end-tidal CO, concentration (E' COI ) were followed during halothane anaesthesia and surgery in 12 intubated, spontaneously breathing children. Body weights ranged from 9.3 to 25 kg and ages from 1 to 5 yr. All patients were free from cardiorespiratory disease. Further patient data are presented in table I.
Anaesthesia was induced with cyclopropane in oxygen (Fi Ol 0.5) and tracheal intubation was facilitated by the injection of suxamethonium chloride 1-1. 5 mg kg" 1 i.v. Respiration was spontaneous throughout and anaesthesia maintained with nitrous oxide and 0.5-2.0% halothane in oxygen. For genital procedures, caudal analgesia was established after the induction of anaesthesia with 0.25 % bupivacaine 0.5 ml kg"
1 . The anaesthetic system was a modified T-piece (Mapleson F system) ( fig. 1 ). Arterial pressure and heart rate were measured automatically at regular intervals the Packard, 14360 A) were placed in the patient limb of the T-piece. FE was measured by electrical integration of the flow signal from a differential pressure manometer (Validyne MP45-1-871, range ± 2 cm H 2 O). E' C0| was measured from the recorded CO, signal and an easily identified plateau phase was required in all cases. The response time of the capnograph was 0.05 s which, from a technical point of view, allowed registration of end-tidal CO, values from a plateau phase at respiratory rates well above those seen in this study. Expired gas passed to a dry gas meter (Standard Gas Meter, AB Nordgas, Stockholm, Sweden) and then to a three-way valve from which a timed collection (over 5 min) of a measured volume of gas could be made into a Douglas bag. The percentage of CO 2 in expired gas (-FE C O|) was measured by the capnograph. Flow, volume and COj, signals were recorded using a u.v. recorder (S.E. Labs (EMI) Ltd, S.E. 3006). Volume was calibrated with a 50-ml syringe. The capnograph was calibrated using certified gas mixtures containing CO 2 within the measuring range. The deadspace of the system was 6 ml and the respiratory resistance of the system, pneumotachograph and in-line paediatric airway adaptor of the capnograph was 10 cm H,O litre" 1 s" 1 with continuous flow rates up to 10 litre min" 1 .
Calculations FE, FT, alveolar ventilation (FA), deadspace volume per breath (FD) and carbon dioxide elimination (Fco,) were corrected to body temperature and pressure saturated (BTPS). The following formulae were used:
where Fi COl is the fraction of CO, in inspired gas and i COl is the mean inspired CO 2 concentration. During rebreathing the mean inspired CO 2 concentration was not known, therefore calculations of FA and FD could not be made. Evaluation of the clinical significance of rebreathing was made according to the criteria detailed by Kain and Nunn (1968) for evidence of alveolar rebreathing (see introduction and table III).
Plan of investigation
The anaesthetist in charge of the patient was not involved in the study, and was at liberty to control the depth of anaesthesia. No measurements were made until anaesthesia was considered clinically stable, the halothane concentration constant and at least 20 min had elapsed since induction.
Measurements of FE, FT, Fl COl , I CO ,, E' COJ , arterial pressure and heart rate were then made with no rebreathing using a fresh gas flow (FGF) which was just great enough to avoid rebreathing (FGF r ). This borderline for rebreathing of CO, was determined in each patient by the use of the capnograph at gradually decreasing FGF. The FGF setting before the one during which CO 2 in inspired gas was first detected (FGF r ) was used during measurements at "no rebreathing".
Then, FGF was decreased to achieve a maximal inspired CO 2 concentration per breath (ico,maxX%) of about 1.5%. Measurements of FE, FT, /, i COt , E' CO ,, arterial pressure and heart rate were obtained just before the change of FGF setting and then every minute during a 5-min period and finally after 10 min of rebreathing. FGF was then returned to its initial value (FGF r ). After a further five minutes of " no rebreathing'' at FGF r , CO a was added to the inspired gas from COj rotameters. A CO S inhalation slightly lower than i C0]mH , that is between 1.0 and 1.5% CO,, was set during this part of the study. The chosen concentration of added CO, was somewhat lower than the maximum CO 2 concentration found during rebreathing so as to produce a CO, load similar to that during rebreathing. The same measurements as during rebreathing were then performed for up to 5 min and finally after 10 min. During the 5th and 10th minute of CO, inhalation samples of expired gas were collected for measurement of F£ COt .
Statistics
Mean values and standard deviation (SD) were calculated. The results were evaluated by the use of paired t test applied to mean data.
RESULTS
Arterial pressure, and heart and respiratory rates were virtually unchanged during periods of rebreathing and CO, inhalation (table II) . The two CO, exposures during inspiration are presented schematically in figure 2. The mean values (±lSD)ofi COtmax andofi COl werel.45±0.38% and 1.24 ±0.32% respectively.
Rebreathing
Th e ico, max (%) given in figure 2 was achieved after the FGF r had been decreased by 44% from (mean±l SD) 5.25±1.58 litre min" 1 to 2.96±0.59 litre min" 1 (P < 0.001). Individual decreases in FGF are illustrated in figure 3 and ranged from 0.7 to 2.5 times the measured minute ventilation. The relationship between the i COt max (%) and the FGF/FE ratio was described by the regression equation: i COimax = -0.71. FGF/ VE + 2A9 with a coefficient of correlation of -0.79 (fig. 4) .
There was considerable variation in response to this level of rebreathing. In no child did E' COI increase significantly and in several no increases were seen in VE and Vr ( fig. 5 ). After 10 min of rebreathing mean VE and FT had increased by 18 and 24%, respectively (ns). Mean respiratory rate and E' COt were unchanged ( fig. 6) .
Only one child fulfilled the criteria of Kain and Nunn for significant rebreathing (table III, fig.  10 ). 
Inhalation of carbon dioxide
The ventilatory response to the inhalation of 1.24 ± 0.32 % carbon dioxide (mean ± 1 SD, fig. 2 ) was similar to that found during rebreathing at low FGF. The seven patients who responded to CO, did so within 2 min. In five patients there were no increases in VE and Vi ( fig. 7 ). E' COt concentrations remained unchanged at this inspired CO 2 concentration. After 10 min of CO 2 inhalation mean values of VE and FT were increased by 18 and 19%, respectively. Respiratory rate and E' COI were unchanged ( fig. 8 ).
Carbon dioxide elimination (FcOj) was unchanged during the inhalation of carbon dioxide. This was achieved by a higher PA which was increased by 32 % (mean value ± 1 SD) from 1212 + 231 ml min" 1 before to 1603 ± 450 ml mkr 1 during CO,, inhalation (P < 0.05)( fig. 9 ). FD/FT ratios (mean±l SD) decreased by 23 % from 0.31 ±0.13 before to 0.24 ±0.12 during COj inhalation (ns) ( fig. 9) .
In spite of the inhalation of carbon dioxide (that is CO 2 present also early during inspiration), the criteria of Kain and Nunn for clinically significant rebreathing were fulfilled in only six of the 12 children ( fig. 10 ).
DISCUSSION
At low fresh gas flows in anaesthetic systems such as Mapleson D, E and F (Willis, Pender and Mapleson, 1975) rebreathing appears late during inspiration. Therefore, apparatus and patient deadspaces could be the only parts exposed to inspired CO 2 . Under these circumstances rebreathing would not create any CO, load as far as the patient is concerned. There are, however, difficulties in calculating the amount of CO, that reaches the alveoli so the clinical importance of rebreathing has still to be judged from ventilatory responses in patients, and criteria for the evaluation of ventilatory changes have been described by Kain and Nunn (1968) . At FGF/FE ratios of 2 with spontaneous breathing in Mapleson D, E and F systems rebreathing is known to occur in most patients (Lindahl, Gharlton and Hatch, 1984) . According to the regression equation for i COt max in this study the level of rebreathing at 2 FGF/K*E would be 1.1% CO,. In the study by Meakins and Coates (1983) however, rebreathing did not occur at 2 FGF/FE. This discrepancy was somewhat surprising since their theoretical mathematical calculations were correctly based on measurements in anaesthetized young patients; but their FGF to VE ratios were derived from the Engstrom and Herzog (1959) nomogram for VE estimations^-published in 1959 for the setting of artificial ventilation which gave minute ventilations which were 30-40 % higher compared with calculations from a recently published regression equation for VE in anaesthetized spontaneously breathing children (Lindahl, Hulse and Hatch, 1984) . If lower 'VE had been used by Meakins and Coates, it is likely that rebreathing would have occurred at higher FGF/ VE ratios.
When FGF was reduced by more than 40% from that precisely required to avoid rebreathing, statistically significant ventilatory changes were not found. One individual demonstrated a marked ventilatory response with an increase in VE of over 50% at an i COi max of 2.15% CO,, which was the highest seen in the sample, but, as the end-tidal CO, tension decreased by almost 1 kPa (patient No. 5, table III) Kain and Nunn's criteria for clinically important rebreathing were not fulfilled. Thus, it was difficult to find evidence of rebreathing within alveolar ventilation. As rebreathing occurs late in inspiration, the volume of rebreathed alveolar gas may stay within the deadspace and hence, not effect alveolar ventilation. Even so, rebreathing within alveolar gas has to be at least in the order of 1-1.25% CO 2 if a uniform ventilatory response was to be expected, since the ventilatory responses during CO, inhalation in this study were as variable as the responses during rebreathing. The six patients fulfilling the criteria during CO S inhalation were surprisingly few, as inhaled CO £ always reaches the alveoli but were, on the other hand, sufficient to indicate that higher levels of alveolar CO 2 rebreathing cannot be accepted clinically.
The similarity in end-tidal carbon dioxide concentrations after lOmin of CO 2 -free breathing, rebreathing or CO 2 inhalation suggests the presence of adequate compensatory respiratory mechanisms balancing COj homeostasis in the body. The compensatory mechanisms during CO 2 inhalation did not primarily result in a uniform increase in minute ventilation. Alveolar ventilation was, however, increased (P < 0.05), indicating an adequate adaptation during CO 2 breathing at the depth of anaesthesia used in this study. An increased VA that was explained most probably by the higher VT noted during CO 2 breathing (which is known to improve ventilation/perfusion ratio (Rose and Froese, 1980) , that is to increase efficiency of ventilation) explained the unchanged E 'coi concentration before and during CO 2 inhalation found in this study.
To achieve a consistent response in VE during rebreathing i co , max °f * -8 % had to be reached, while lower concentrations resulted in variable responses (table III) . According to the regression equation for the relationship between i COl max and FGF/FE, FGF settings lower than VE are likely to result in rebreathing within the alveolar ventilation. Such low fresh gas flows are at the utmost limit which can be tolerated in clinical practice using these breathing systems. During anaesthesia many things can go wrong; one of them being insufficient CO 2 elimination. Since, CO 2 is a factor which we know how to eliminate from inspired gas, fresh gas flows of at least 1.5 to 2 times VE must be used to keep the maximal inspired CO 2 concentration within acceptable limits to achieve a necessary margin of safety in anaesthetized spontaneously breathing children. If the total elimination of rebreathing is desired, a fresh gas flow of 3.5 times VE is required, according to the regression equation calculated in this study.
It was concluded that at an ico,max °f l-45± 0.38% resulting from low fresh gas flows, VE increased by 18% (ns) and E' COI was unchanged. Criteria for clinically important CO 2 rebreathing were only fulfilled in one patient. During the inhalation of 1.24 ±0.32% CO,, VE was also increased by 18% (ns) and E' COl was unchanged. Although, VE did not increase significantly during the inhalation of 1.24 ±0.32% CO 2 , VA did, indicating an intact and adequate ventilatory response to this level of CO 2 breathing during halothane anaesthesia. Estimations of i C ojmax could be made from the expression: i C q t max = -0.7 x FGF/FE + 2.5 and FGF to VE ratios lower than 1 are likely to result in clinically significant rebreathing with i C o,max concentrations of more than 1.8%. To avoid alveolar rebreathing, FGF settings of at least 1.5 to 2 times VE must be used in these anaesthetic systems.
